BSc MBBS PhD MD DSc
Research Leader, Institute for Glycomics
Contact details for Professor Michael Good
Research Interests
Immunity and immunopathogenesis to malaria and group A streptococcus/rheumatic fever, with particular relevance to the development of vaccines.
Publications
- Good, M.F., Maloy, W.L., Lunde, M.N., Margalit, H., Cornette, J.L., Smith, G.L., Moss, B., Miller, L.H., and Berzofsky, J.A. Construction of a synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science 235: 1059-1062, 1987.
- Good, M.F., Pombo, D., Quakyi, I.A., Riley, E.M., Houghten, R.A., Menon, A., Alling, D.W., Berzofsky, J.A. and Miller, L.H. Human T cell recognition of the circumsporozoite protein of Plasmodium falciparum. Immunodominant T cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA 85: 1199-1203, 1988.
- Weiss, W.R., Sedegah, M., Beaudoin, R.L., Miller, L.H. and Good, M.F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85: 573-557, 1988.
- Pruksakorn, S., Currie, B., Brandt, E., Martin, D., Galbraith, A., Phornphutkul, C., Hunsakunachai, S., Manmontri, A. and Good, M.F. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on the M protein of group A streptococcus. The Lancet (article) 344: 639-642, 1994.
- Pombo, D.L., Lawrence, G., Hirunpetcharat, C., Rzepczyk, C., Bryden, M., Cloonan, M., Anderson, K., Mahakunkicharoen, Y., Elliott, S., Eisen, D.P., Saul, A. and Good, M.F. Immunity to malaria in humans after administration of ultra low doses of red cells infected with Plasmodium falciparum. The Lancet 30: 610-617, 2002.